File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis

TitleLong-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis
Authors
KeywordsIntensity-modulated radiation therapy (IMRT)
Long-term outcomes
Nasopharyngeal (NPC)
Quality of life (QoL)
Replanning
Issue Date1-May-2022
PublisherElsevier
Citation
Radiotherapy & Oncology, 2022, v. 170, p. 136-142 How to Cite?
Abstract

Background and purpose

Recent studies show that adaptive replanning for patients with nasopharyngeal carcinoma (NPC) during intensity-modulated radiation therapy (IMRT) improve the short-term local–regional recurrence-free survival (LRFS), and quality of life (QoL). We aimed to assess the long-term survival outcomes and QoL in patients with non-metastatic NPC who received IMRT with replanning compared to those who received IMRT without replanning.

Methods and materials

We conducted an updated and expanded retrospective analysis from an existing prospective cohort for non-metastatic NPC patients undergoing IMRT in our institution. Non-metastatic NPC patients receiving IMRT from June 2007 to December 2015 were consecutively enrolled based on electronic medical record. Patients who were still alive were eligible for the QoL study. The survival outcomes and QoL were compared between patients with and without replanning.

Results

Among 290 patients, 147 (50.7%) received IMRT without replanning and 143 (49.3%) received IMRT with replanning. Replanning group had a higher 8-year LRFS rate (87.4% vs. 75.6%, P = 0.025). However, 8-year overall survival rate was not statistically significant. Patients with replanning compared to those who without replanning had significant improvements in social functioning (P = 0.016), insomnia (P = 0.048), dry mouth (P = 0.004), and sticky saliva (P = 0.005). Additionally, the score of the role functioning was marginally higher in patients treated with IMRT replanning (P = 0.063).

Conclusion

This extended follow-up study demonstrates the long-term security and validity for adaptive radiotherapy in IMRT for non-metastatic NPC patients. We highly recommend that adaptive replanning should be routinely implemented for non-metastatic NPC patients.


Persistent Identifierhttp://hdl.handle.net/10722/343928
ISSN
2023 Impact Factor: 4.9
2023 SCImago Journal Rankings: 1.702

 

DC FieldValueLanguage
dc.contributor.authorZhou, Xiate-
dc.contributor.authorWang, Wei-
dc.contributor.authorZhou, Chao-
dc.contributor.authorZhu, Jian-
dc.contributor.authorDing, Weijun-
dc.contributor.authorChen, Meng-
dc.contributor.authorChen, Kuifei-
dc.contributor.authorShi, Yangyang-
dc.contributor.authorChen, Xiaofeng-
dc.contributor.authorKong, FS-
dc.contributor.authorYang, Haihua-
dc.date.accessioned2024-06-18T03:42:53Z-
dc.date.available2024-06-18T03:42:53Z-
dc.date.issued2022-05-01-
dc.identifier.citationRadiotherapy & Oncology, 2022, v. 170, p. 136-142-
dc.identifier.issn0167-8140-
dc.identifier.urihttp://hdl.handle.net/10722/343928-
dc.description.abstract<h3>Background and purpose</h3><p>Recent studies show that adaptive replanning for patients with nasopharyngeal carcinoma (NPC) during intensity-modulated radiation therapy (IMRT) improve the short-term local–regional recurrence-free survival (LRFS), and quality of life (QoL). We aimed to assess the long-term survival outcomes and QoL in patients with non-metastatic NPC who received IMRT with replanning compared to those who received IMRT without replanning.</p><h3>Methods and materials</h3><p>We conducted an updated and expanded retrospective analysis from an existing prospective cohort for non-metastatic NPC patients undergoing IMRT in our institution. Non-metastatic NPC patients receiving IMRT from June 2007 to December 2015 were consecutively enrolled based on electronic medical record. Patients who were still alive were eligible for the QoL study. The survival outcomes and QoL were compared between patients with and without replanning.</p><h3>Results</h3><p>Among 290 patients, 147 (50.7%) received IMRT without replanning and 143 (49.3%) received IMRT with replanning. Replanning group had a higher 8-year LRFS rate (87.4% vs. 75.6%, <em>P</em> = 0.025). However, 8-year overall survival rate was not statistically significant. Patients with replanning compared to those who without replanning had significant improvements in social functioning (<em>P</em> = 0.016), insomnia (<em>P</em> = 0.048), dry mouth (<em>P</em> = 0.004), and sticky saliva (<em>P</em> = 0.005). Additionally, the score of the role functioning was marginally higher in patients treated with IMRT replanning (<em>P</em> = 0.063).</p><h3>Conclusion</h3><p>This extended follow-up study demonstrates the long-term security and validity for adaptive radiotherapy in IMRT for non-metastatic NPC patients. We highly recommend that adaptive replanning should be routinely implemented for non-metastatic NPC patients.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofRadiotherapy & Oncology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectIntensity-modulated radiation therapy (IMRT)-
dc.subjectLong-term outcomes-
dc.subjectNasopharyngeal (NPC)-
dc.subjectQuality of life (QoL)-
dc.subjectReplanning-
dc.titleLong-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis-
dc.typeArticle-
dc.identifier.doi10.1016/j.radonc.2022.03.007-
dc.identifier.scopuseid_2-s2.0-85128211676-
dc.identifier.volume170-
dc.identifier.spage136-
dc.identifier.epage142-
dc.identifier.issnl0167-8140-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats